Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma
Clinical trial NCT05799612 · WITHDRAWN
Trial details
- NCT number
- NCT05799612
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-22
- Primary completion
- 2024-11-05
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.